# Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)

> **NCT04681651** · PHASE2 · COMPLETED · sponsor: **Capital Medical University** · enrollment: 282 (actual)

## Conditions studied

- Stroke, Acute
- Neuroprotection

## Interventions

- **DRUG:** Normobaric Hyperoxia
- **DRUG:** Sham Normobaric Hyperoxia
- **PROCEDURE:** Endovascular Thrombectomy

## Key facts

- **NCT ID:** NCT04681651
- **Lead sponsor:** Capital Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-22
- **Primary completion:** 2023-05-05
- **Final completion:** 2023-05-05
- **Target enrollment:** 282 (ACTUAL)
- **Last updated:** 2023-07-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04681651

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04681651, "Normobaric Hyperoxia Combined With Endovascular Treatment in Acute Ischemic Stroke (OPENS-2)". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04681651. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*